The judge overseeing Philadelphia’s Zantac mass tort did not look favorably upon a bid from plaintiffs to boot him from the litigation.

In a Tuesday opinion, Judge Joshua Roberts of the Philadelphia Court of Common Pleas said the Zantac plaintiffs “fell woefully short of presenting any concrete facts that could support recusal.”